Modulatory effect of S-allylcysteine on glucose metabolism in streptozotocin induced diabetic rats

Journal of Functional Foods

Volumn 1, Issue 4, 2009, Pages 336-340

  Saravanan, Ganapathy ^a,b   Ponmurugan, Ponnusamy ^a,c   Senthilkumar, Gandhipuram Periasamy ^b   Rajarajan, Thatchinamoorthi ^d  

^a BHARATHIAR UNIVERSITY   (India)

^b K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

^c K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

^d SASTRA UNIVERSITY   (India)

Author keywords

Diabetes; S Allylcysteine; Streptozotocin

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 70449722823     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2009.09.001     Document Type: Article

References (35)

1. Alarcon-Aguilara F.J., Roman-Ramos R., Perez-Gutierrez S., Aguilar-Contreras A., Contreras-Weber C.C., and Flores-Saenz J.L. Study of the anti-hyperglycemic effect of plants used as antidiabetics. Journal of Ethnopharmacology 61 (1998) 101-110
2. Balkau B., Charles M.A., and Eschwège E. Discussion épidémiologique des nouveaux critères du diabète. Mt Endocrinologie 2 (2000) 229-234
3. Baquer N.Z., Gupta D., and Raju J. Regulation of metabolic pathways in liver and kidney during experimental diabetes. Indian Journal of Clinical Biochemistry 13 (1998) 63-80
4. Bollen M., Keppens S., and Stalmans W. Specific features of glycogen metabolism in the liver. Biochemical Journal 336 (1998) 19-31
5. Bopanna K.N., Kannan J., Sushma G., and Balaraman R. Antidiabetic and antihyperlipidemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian Journal of Pharmacology 29 (1997) 162-167
6. Boyle J.P., Honeycutt A.A., and Narayan K.M. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US. Diabetes Care 24 (2001) 1936-1940
7. Chu Q., Lee D.T., Tsao S.W., Wang X., and Wong Y.C. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU International 99 (2007) 925-932
8. Cornblath M., Randle P., Parmeggiani J.A., and Morgan H.E. Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. Journal of Biological Chemistry 238 (1963) 1592-1597
9. Ferrer J.C., Favre C., and Gomis R.R. Control of glycogen deposition. FEBS Letter 546 (2003) 127-132
10. Gancedo J.M., and Gancedo C. Fructose-1,6-bis-phosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting yeast. Archives Microbiology 76 (1971) 132-138
11. Gannon M.C., and Nuttall F.Q. Effect of feeding, fasting and diabetes on liver glycogen synthase activity, protein, and mRNA in rats. Diabetologia 40 (1997) 758-763
12. Garvey W.T. Glucose transport and NIDDM. Diabetes Care 15 (1992) 396-417
13. Gayathri M., and Kannabiran K. Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozotocin induced diabetic rats. Indian Journal of Clinical Biochemistry 23 4 (2008) 394-400
14. Grover J.K., and Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: A review. Journal of Ethnopharmacology 93 (2004) 123-132
15. Gupta B.L., Nehal M., and Baquer N.Z. Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Indian Journal of Experimental Biology 35 (1997) 792-795
16. Harrower A.D. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. Journal of Diabetes Complication 8 (1994) 201-203
17. Herrera-Mundo M.N., Silva-Adaya D., Maldonado P.D., Galvan-Arzate S., Andres-Martinez L., Perez-De La Cruz V., Pedraza-Chaverri J., and Santamaria A. S-allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity early markers of oxidative stress and mitochondrial dysfunction. Neuroscience Research 56 (2006) 39-44
18. Ikino H., Kobayashi M., Suzuki Y., and Konno C. Mechanism of hypoglycemic activity of aconitan A, a glycan from Aconitum carmichaelii roots. Journal of Ethnopharmacology 25 (1989) 295-304
19. Park J.-K., Kim S.-P., and Song D.-K. Ameliorating effects of sulfonylurea drugs on insulin resistance in Otsuka Long-Evans Tokushima fatty rats. Korean Journal of Physiology Pharmacology 12 (2008) 7-12
20. King H., Aubert R.E., and Hermen W.H. Global burden of diabetes 1995-2025 prevalence, numerical estimates and projections. Diabetes Care 21 (1998) 1414-1431
21. Koida H., and Oda T. Pathological occurrence of glucose-6-phosphatase in liver disease. Clinica Chimica Acta 4 (1959) 554-561
22. Leloir L., and Goldenber S.H. Glycogen synthase from rat liver. In: Kolowick S.P., and Kaplan O.P. (Eds). Methods of enzymology (1962), Academic Press, New York, NY 145-148
23. Lapeir T.K., and Rodnick K.J. Effects of aerobic exercise on energy metabolism in the hypertensive rat heart. Physical Therapy 81 4 (2001) 1006-1017
24. McKenna D.J., Jones K., Hughes K., and Humphrey S. Botanical medicines, the desk reference for major herbal supplements. 2nd ed. (2002), The Haworth Herbal Press, New York, NY pp. 22-28
25. Minnassian C., and Mitheux G. Differential time course of liver and kidney glucose-6-phosphatase activity during fasting in rats. Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology 109 (1994) 99-104
26. Moriguchi T., Matsura H., Kodera Y., Itakura Y., Katsuki H., Saito H., and Nishiyama N. Neurotrophic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons. Neurochemistry Research 22 (1997) 1449-1452
27. Murray R.K., Granner D.K., Mayes P.A., and Rodwell V.W. Harper's Biochemistry. 25th ed. (2000), Appleton & Lange, Stanford, Connecticut pp. 610-617
28. Ong K.C., and Khoo H.-E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sciences 67 (2000) 1695-1705
29. Palsamy P., and Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomedicine & Pharmacotherapy 62 (2008) 598-605
30. Papaccio G., Pisanti F.A., Latronico M.V., Ammendola E., and Galdieri M. Multiple low dose and single high dose treatments with streptozotocin do not generate nitric oxide. Journal Cell Biochemistry 77 (2000) 82-91
31. Pulido N., Suarez A., Casanova B., Romero R., Rodriguez E., and Rovira A. Glyclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metabolism 46 (1997) 10-13
32. Kaleem M., Asif M., Ahmed Q., and Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin induced diabetic rats. Singapore Medical Journal 47 8 (2006) 670-675
33. Saravanan G., Ponmurugan P., Senthil kumar G.P., and Rajarajan T. Antidiabetic properties of S-allylcysteine, a garlic component on streptozotocin-induced diabetes in rats. Journal of Applied Biomedicine 7 (2009) 151-159
34. Senthil kumar G.P., Arulselvan P., Sathiskumar D., and Subramanian S. Antidiabetic activity of fruits of Terminalia chebula on streptozotocin induced diabetes in rats. Journal of Health Science 52 (2006) 283-291
35. Venkateswaran S., and Pari L. Effect of Coccinia indica on blood glucose, insulin and hepatic key enzymes in experimental diabetes. Pharmaceutical Biology 40 (2002) 165-170